Hap Trading, LLC Red Hill Biopharma Ltd. Call Options Transaction History

Hap Trading, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$0.5 - $523.8 $150 - $157,140	300 Added 2.42%	12,700 $0
Q2 2022 Aug 12, 2022	SELL	$0.63 - $2.58 $1,953 - $7,998	-3,100 Reduced 20.0%	12,400 $1,000
Q1 2022 May 12, 2022	BUY	$1.65 - $3.12 $25,575 - $48,360	15,500 New	15,500 $8,000
Q3 2021 Nov 10, 2021	SELL	$4.55 - $10.36 $61,880 - $140,896	-13,600 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$5.98 - $7.51 $81,328 - $102,136	13,600 New	13,600 $3,000

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $465M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.